Can you provide the last earnings date for CHINOOK THERAPEUTICS INC?
CHINOOK THERAPEUTICS INC (KDNY) last reported earnings on 8/7/2023.
NASDAQ:KDNY • US16961L1061
Past quarterly earnings results for CHINOOK THERAPEUTICS INC (KDNY), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | -0.94 | -0.83 | -13.35% | -54.10% | 1.008M | 244.8K | 311.76% | 141.15% |
| Q1 2023 | -0.85 | -0.81 | -4.85% | -57.41% | 1.828M | 244.8K | 646.73% | -32.22% |
| Q4 2022 | -0.90 | -0.81 | -11.69% | -742.86% | 512K | 102K | 401.96% | -99.00% |
| Q3 2022 | -0.83 | -0.64 | -30.05% | -20.29% | 2.501M | 102K | 2,351.96% | 62,425.00% |
| Q2 2022 | -0.61 | -0.63 | 2.49% | 46.49% | 418K | 425.003K | -1.65% | 1,129.41% |
| Q1 2022 | -0.54 | -0.68 | 20.51% | 38.64% | 2.697M | - | 670.57% | |
| Q4 2021 | 0.14 | -0.69 | 120.30% | 111.29% | 51.236M | - | 327.92% | |
| Q3 2021 | -0.69 | -0.86 | 19.31% | 23.33% | 4K | 42.503K | -90.59% | -99.89% |
| Q2 2021 | -1.14 | -0.80 | -42.68% | -8.57% | 34K | 42.503K | -20.01% | -99.39% |
| Q1 2021 | -0.88 | -0.69 | -27.50% | -95.56% | 350K | 51K | 586.27% | -97.49% |
| Q4 2020 | -1.24 | -0.45 | -173.19% | - | -22.48M | 2.525M | -990.30% | - |
| Q3 2020 | -0.90 | -0.46 | -93.92% | - | 3.79M | 3.91M | -3.07% | - |
| Q2 2020 | -1.05 | -0.97 | -8.36% | - | 5.57M | 3.523M | 58.10% | - |
| Q1 2020 | -0.45 | -0.69 | 34.64% | - | 13.95M | 10.705M | 30.31% | - |
Notes
CHINOOK THERAPEUTICS INC (KDNY) last reported earnings on 8/7/2023.
CHINOOK THERAPEUTICS INC (KDNY) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, CHINOOK THERAPEUTICS INC (KDNY) has beaten EPS estimates in 0 out of 4 releases.